These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7349819

  • 1. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B, Benvenuti M, Legnaioli M, Bazzani M, Cagnoni M, Halberg F.
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [Abstract] [Full Text] [Related]

  • 2. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B, Gheri R, Romano S, Costa A, Cagnoni M, Lee JK, Halberg F.
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Toward chronobiologic pattern discrimination of the risk of developing breast cancer and other diseases.
    Hermida Domínguez RC, Halberg F, del Pozo F, Haus E.
    Rev Esp Oncol; 1982; 29(2):199-267. PubMed ID: 6765184
    [Abstract] [Full Text] [Related]

  • 5. Possible linkage between the ability to change the period (tau) of the prolactin and cortisol rhythms in women and breast cancer risk.
    Lewy H, Haus E, Ashkenazi IE.
    Chronobiol Int; 2007; 24(2):365-81. PubMed ID: 17453854
    [Abstract] [Full Text] [Related]

  • 6. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W, von Heyden D, Rauschecker H, Nagel GA.
    Schweiz Med Wochenschr; 1983 Oct 15; 113(41):1513-20. PubMed ID: 6635641
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC, Sellwood RA, Knyba RE, Irvine JD.
    Clin Oncol; 1981 Sep 15; 7(3):213-9. PubMed ID: 6211319
    [No Abstract] [Full Text] [Related]

  • 9. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J, Rebhan EM, Prestele H, Becker H.
    Geburtshilfe Frauenheilkd; 1980 Jan 15; 40(1):65-71. PubMed ID: 7353778
    [Abstract] [Full Text] [Related]

  • 10. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C, Ferrer S, Merle S, Sanchis V, Camps Roig J, Giménez Climent J.
    Rev Esp Oncol; 1983 Jan 15; 30(3):323-36. PubMed ID: 6571376
    [Abstract] [Full Text] [Related]

  • 11. Assessment of the risk of mesor-hypertension.
    Hermida-Dominguez RC, Halberg F.
    Chronobiologia; 1984 Jan 15; 11(3):249-62. PubMed ID: 6510120
    [Abstract] [Full Text] [Related]

  • 12. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
    Romppanen J, Keskikuru R, Kataja V, Eskelinen M, Kosma VM, Savolainen K, Uusitupa M, Mononen I.
    Br J Cancer; 1999 Mar 15; 79(9-10):1583-7. PubMed ID: 10188910
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Fibrocystic disease of breast and pituitary-thyroid axis function].
    Zych F, Mizia-Stec K, Mucha Z, Zych-Twardowska E.
    Pol Merkur Lekarski; 1996 Oct 15; 1(4):227-8. PubMed ID: 9156929
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
    Korolev VI, Skliar SIu, Ponomarev IN.
    Vrach Delo; 1988 Jan 15; (1):59-61. PubMed ID: 3363942
    [No Abstract] [Full Text] [Related]

  • 20. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease.
    Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H, Araki E.
    Jpn J Cancer Res; 1985 May 15; 76(5):374-7. PubMed ID: 3924710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.